About conolidine
These results, along with a prior report displaying that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,2 guidance the principle of focusing on ACKR3 as a novel solution to modulate the opioid program, which could open new therapeutic avenues for opioid-associated Issues.(2) The medical doctor has received a created